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Bacterial type IV secretion systems (T4SS) mediate interbacterial
conjugative DNA transfer and transkingdom protein transfer into
eukaryotic host cells in bacterial pathogenesis. The sole bacterium
known to naturally transfer DNA into eukaryotic host cells via
a T4SS is the plant pathogen Agrobacterium tumefaciens. Here we
demonstrate T4SS-mediated DNA transfer from a human bacterial
pathogen into human cells. We show that the zoonotic pathogen
Bartonella henselae can transfer a cryptic plasmid occurring in the
bartonellae into the human endothelial cell line EA.hy926 via its
T4SS VirB/VirD4. DNA transfer into EA.hy926 cells was demon-
strated by using a reporter derivative of this Bartonella-speciﬁc
mobilizable plasmid generated by insertion of a eukaryotic egfp-
expression cassette. Fusion of the C-terminal secretion signal of the
endogenous VirB/VirD4 protein substrate BepD with the plasmid-
encoded DNA-transport protein Mob resulted in a 100-fold in-
creased DNA transfer rate. Expression of the delivered egfp gene
in EA.hy926 cells required cell division, suggesting that nuclear en-
velope breakdown may facilitate passive entry of the transferred
ssDNA into the nucleus as prerequisite for complementary strand
synthesis and transcription of the egfp gene. Addition of an eukary-
otic neomycin phosphotransferase expression cassette to the re-
porter plasmid facilitated selection of stable transgenic EA.hy926
cell lines that display chromosomal integration of the transferred
plasmid DNA. Our data suggest that T4SS-dependent DNA transfer
into host cells may occur naturally during human infection with
Bartonella and that these chronically infecting pathogens have po-
tential for the engineering of in vivo gene-delivery vectors with
applications in DNA vaccination and therapeutic gene therapy.
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Bacterial type IV secretion systems (T4SS) are membrane-spanning supramolecular protein assemblies that represent
versatile transporters facilitating the transfer of different mac-
romolecular substrates (protein or protein/DNA complexes)
from the bacterial cytoplasm into various target cells of bacterial,
mammalian, or plant origin or directly into the extracellular
milieu (1). The ancestral T4SS has probably evolved to facilitate
conjugative DNA transfer between bacteria (2). Conjugative
plasmids encode such bacterial conjugation systems and thus
promote their own spread or that of coresiding mobilizable
plasmids among bacteria. Conjugation systems encode a nicking
enzyme (relaxase, Mob protein) recognizing the origin of trans-
fer (oriT) of the conjugative/mobilizable plasmid. Upon binding
to oriT the relaxase nicks one strand of the dsDNA and co-
valently attaches to the 5′ end of the resulting ssDNA. Con-
comitant to the elongation of the ssDNA at its 3′ end by rolling-
cycle replication, the relaxase then serves as a pilot protein for
directing 5′-to-3′ transfer of the attached linear ssDNA into the
recipient cell. Recircularization of the transferred ssDNA and
second strand synthesis then results in the generation of a cir-
cular dsDNA plasmid (3). Such conjugation systems not only
mediate DNA transfer between bacteria; some of them have also
been shown to be capable of mediating transkingdom DNA
transfer into yeast (4, 5) or mammalian cells (6).
Several pathogenic bacteria have adopted bacterial conjuga-
tion systems for interkingdom transfer of macromolecular sub-
strates into eukaryotic target cells or the extracellular milieu.
These pathogenesis-associated T4SSs transport protein/ssDNA
complexes like in bacterial conjugation or are reduced to protein
transfer systems (1). They even may function in bacterial patho-
genesis independently of any noticeable substrate transfer (7, 8).
The VirB/VirD4 system of the plant pathogen Agrobacterium
tumefaciens is the only known pathogenesis-associated T4SS that
naturally facilitates conjugation-like DNA transfer to eukaryotic
host cells (9). This T4SS mediates the transfer of a complex of
the VirD2 relaxase and a covalently attached single stranded
transfer DNA (T-DNA) derived from the tumor-inducing plas-
mid into infected plant cells. With the aid of additional virulence
proteins, i.e., the cotransferred ssDNA-binding protein VirE2,
the T-DNA is protected and targeted to the nucleus, where it
integrates into the plant genome, leading to the expression of T-
DNA encoded genes, which ultimately results in tumor forma-
tion. In addition to numerous reports on structure/function
analysis of this paradigmatic T4SS machinery and the de-
velopment of an efﬁcient gene delivery system for plant genetic
engineering, the A. tumefaciens VirB/VirD4 T4SS was also
reported to be capable of transforming human cells under non-
physiological laboratory conditions (10). However, this plant
cell-targeting DNA-delivery system is adapted to function at
ambient temperatures but is entirely nonfunctional at human
body temperature and therefore hitherto has failed to ﬁnd any
application in DNA vaccination or gene therapy.
The majority of the pathogenesis-associated T4SSs translocate
bacterial effector proteins into mammalian host cells that subvert
cellular functions to promote the host-associated lifestyle of the
pathogen (11). Prominent examples are the Cag T4SS of Heli-
cobacter pylori, which transfers the CagA effector protein into
gastric epithelial cells, thereby mediating various cellular changes
related to gastric disease (12); and the Dot/Icm T4SS of
Legionella pneumonia, which transfers numerous effector pro-
teins into amoebae or mammalian macrophages that facili-
tate the establishment of an intracellular bacterial replication
niche (13). Of note, it has been demonstrated that some of
these pathogenesis-associated T4SSs maintained their ancestral
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conjugative function; i.e., plasmid mobilization was shown for
the L. pneumonia Dot/Icm system between bacteria (14) or the
A. tumefaciens VirB/VirD4 T4SS between bacteria (15) and
from Agrobacterium to plants (16).
T4SS also play prominent roles in the pathogenesis of species
of the genus Bartonella (7, 17). The zoonotic pathogen Bartonella
henselae causes an asymptomatic blood infection in its cat res-
ervoir host, whereas incidental transmission to humans causes
a benign inﬂammation of lymph nodes in immunocompetent
patients known as cat-scratch disease or a vascular proliferative
disease in immunocompromised patients known as bacillary
angiomatosis (18). B. henselae uses a VirB/VirD4 T4SS to
translocate a mixture of seven Bartonella effector proteins (Beps)
into human endothelial cells (19). These Beps contain a con-
served Bep intracellular delivery (BID) domain close to the C
terminus, which, together with a C-terminal positively charged
tail sequence, constitutes a bipartite signal for T4SS-mediated
protein translocation. Importantly, BID domains are also present
in the relaxases of a subset of bacterial conjugation systems, and
the BID domain of the TraA relaxase encoded by the cryptic
plasmid pATC58 of A. tumefaciens was shown to be functional as
secretion signal for the B. henselae VirB/VirD4 T4SS (19). This
ﬁnding prompted us to test whether, in addition to its well
characterized role in intracellular protein delivery, the VirB/
VirD4 T4SS of B. henselae may be capable of mobilizing DNA
into human cells. Based on derivates of the Bartonella-speciﬁc
mobilizable plasmid pBGR1, which encodes a relaxase (Mob)
and an oriT (20), we demonstrate DNA transfer into human cells
in a VirB/VirD4-dependent and relaxase-dependent manner, and
show that fusion of the secretion signal of the native VirB/VirD4
protein substrate BepD to the relaxase greatly increases the
DNA transfer efﬁciency. We further provide evidence indicating
that breakdown of the nuclear envelope and/or active replication
of the host DNA is required for expression of the eukaryotic egfp
cassette encoded by the transferred plasmid. Finally, we dem-
onstrate that transgenic cell lines stably expressing the trans-
ferred plasmid DNA can be selected as a result of recombination
with the host cell genome.
Results
B. henselae Translocates Plasmid DNA into Human Cells via the VirB/
VirD4 T4SS. To test whether the VirB/VirD4 T4SS of B. henselae
may—in addition to its role in intracellular protein delivery—be
capable of mobilizing DNA into human cells, we took advantage
of the Bartonella-speciﬁc cryptic plasmid pBGR1, which, as its
only discernable genetic elements, encodes a replication protein
(Rep) and respective origin of replication (oriV), as well as
a relaxase (Mob) and respective oriT (20). Although the Mob
relaxase of pBGR1 does not contain a recognizable BID-like
domain, we wondered whether this naturally occurring mobiliz-
able plasmid might transfer into human cells during the course of
infection. To monitor plasmid transfer, we introduced into B.
henselae WT the plasmid pRS117, which is a pBGR1 derivative
carrying an egfp reporter cassette under control of the CMV
promoter that would mediate eukaryote-speciﬁc expression of
EGFP (Fig. 1A). As negative controls, we included the T4SS-
deﬁcient ΔvirB4 strain carrying pRS117, as well as the WT strain
carrying a derivative of pRS117 in which the mob gene is dis-
rupted (pRGS06). Noteworthy, despite the deﬁciency for effector
protein secretion, the ΔvirB4 strain does not display reduced vi-
ability during infection of the human endothelial cell line Ea.
hy926 (21). After 3-d infections of Ea.hy926 cells with the dif-
ferent B. henselae strains, the cell populations were analyzed by
ﬂow cytometry to determine the percentages of GFP-positive
cells (gpc) as functional readout for gene transfer and expression
of the eukaryote-speciﬁc egfp reporter cassette (Fig. 1 B and C).
DNA transfer was detectable in cells infected with the WT strain
carrying pRS117 (0.02% gpc), whereas infection with both con-
trol strains did not give rise to any detectable transfer event
(detection limit, 0.003%). These data clearly demonstrate the
transfer of the reporter plasmid pRS117 by B. henselae into hu-
man cells, and that this DNA transfer process is dependent on
a functional VirB/VirD4 T4SS as well as the Mob relaxase.
Fusion of Type IV Secretion Signal from Native VirB/VirD4 Substrate
to Mob Dramatically Increases Efﬁciency of DNA Transfer into Human
Cells. In an effort to increase transfer efﬁciency, we fused to the C
terminus of Mob the previously characterized C-terminal secre-
tion signal of the VirB/VirD4 effector protein BepD (19), which
consists of a BID-domain and a positively charged C-terminal
tail. Strikingly, infections with WT B. henselae carrying pRS122
encoding this Mob/BID fusion protein (Fig. 1A) showed an ap-
proximately 100-fold–increased transfer rate to EAhy.926 cells
compared with the pRS117 reference plasmid encoding the na-
tive Mob relaxase (Fig. 1 B–D). These results support a correla-
tion between Mob transfer rates and gene transfer rates and
conﬁrm the role of the relaxase as a pilot protein for the trans-
location of the plasmid DNA via the VirB/VirD4 T4SS (Fig. 1E),
similarly as already demonstrated for the VirD2 protein during
the delivery of the VirD2/T-DNA complex into plant cells (22).
Integration of Translocated Plasmid DNA into Host Cell Chromosome.
To test whether the DNA transferred by this VirB/VirD4-de-
pendent mechanism can integrate into the EAhy.926 chromo-
some, we included a resistance marker (neo) to facilitate
geneticin selection of stable transfected cell lines, resulting in
plasmid pRS130. Southern blot analysis of the genomic DNA of
eight different geneticin-resistant cell lines (A–H) revealed that
the entire pRS130 plasmid or parts of it had integrated into the
genome (Fig. S1). Mapping of the transferred DNA with plasmid
speciﬁc probes followed by PCR-based reﬁnement revealed
heterogeneity in the DNA integration patterns (Fig. 2A, Table
S1, and SI Results). In four cases, the integration was largely
restricted to the plasmid region encoding the neo resistance
marker (cell lines D, E, G, and H). In two established cell lines,
evidence was found that a plasmid fragment spanning the oriT
region had been integrated (cell lines B and F), which could
reﬂect the transfer and integration of a plasmid concatemer, as
results from rolling-cycle replication or the integration of the
plasmid DNA subsequent to precise recircularization at the oriT.
To investigate whether, as in the case of VirD2 and the bound 5′
end of the A. tumefaciens T-DNA, the Mob relaxase can protect
the plasmid DNA proximal to the oriT (23, 24), we mapped some
representative integration borders by using thermal asymmetric
interlaced (TAIL)-PCR (10, 25). Sequence analysis of the 5′
integration border in cell line C revealed that the junction to
chromosomal DNA has occurred next to the oriT of pRS130
(Fig. 2B). This junction is reminiscent of an illegitimate re-
combination event, as it contains a 47-bp ﬁller DNA (24) that
consists of an inverted repeat in the 22 bp upstream of the oriT,
followed by 25 bp showing short stretches of homology to both
pRS130 and the human chromosomal insertion site. The three
other integration sites (cell lines A, D, and E) presented in Fig.
S2 do not share these characteristics, as no sequence similarity to
the oriT has been detected. In the four cell lines (A, C, D, and E)
for which the junctions were determined, the integrations lie in
unrelated sequences of chromosomes 22, 4, 2, and 7, re-
spectively, and thus no preference for speciﬁc integration sites
could be distinguished. Taken together, our results show that the
Mob protein can protect the 5′ end of the transferred DNA and
suggest a mechanism of integration similar to what has been
reported for the VirD2-bound T-DNA of A. tumefaciens (23, 24).
Expression of a Delivered egfp Gene Requires Cell Division. Several
processes may interfere with the expression of ssDNA delivered
into the cytoplasm of EAhy.926 cells (Fig. 1E). In the case of the
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A. tumefaciens T-DNA transfer system for plant cells, the
cotransferred ssDNA-binding protein VirE2 protects the naked
T-DNA from degradation and assists passage of membranes by
its pore-forming activity (26). Additionally, VirE2 and the 5′-
bound VirD2 carry nuclear localization signals (NLSs), which
facilitate import through the nuclear pore complex (27–29). In
case of B. henselae plasmid transfer to EAhy.926 cells, there is no
evidence for the existence of such helping factors, and the Mob
relaxase does not contain any noticeable NLSs. Thus, nuclear
uptake of the ssDNA may exclusively occur upon disassembly of
the nuclear envelope during mitotic cell division. As cell division
of the Ea.hy926 cell line is contact-inhibited, we measured the
percentage of gpc of cell monolayers infected at different stages
of conﬂuence. Our results indicate that the expression of the
translocated DNA inversely correlated with the cell density and
thus appears to depend on cell division (Fig. 3A). In contrast,
protein transfer as measured by the previously reported Cre
recombinase assay for translocation (19) positively correlates
with cell densities and is thus independent of cell division (Fig.
3A). Time-course experiments support these notions: whereas
protein transfer rates constantly increased over a period of 6 d of
infection, the rates of DNA transfer/expression reached a steady
state at day 3 or 4 when the monolayers reached conﬂuence and
cell divisions ceased (Fig. 3B). Together these results suggest
that the transferred DNA enters the nucleus passively after
disassembly of the nuclear envelope, although we cannot exclude
the sole or additional requirement for active DNA replication—
which occurs during cell division—to allow recombination/in-
tegration to happen.
Discussion
T4SSs are known to transport different macromolecular sub-
strates into diverse target cell types and thus are considered to
represent the most versatile class of bacterial secretion systems
(11). However, naturally occurring transkingdom DNA transfer
has been described only for the pathogenic A. tumefaciens–plant
interaction. In this report, we describe T4SS-mediated DNA
transfer from a human pathogenic bacterium into cultured hu-
man cells that possibly may occur naturally during human in-
fection. We demonstrate here that a derivative of the Bartonella-
speciﬁc cryptic plasmid pBGR1 (20) is transferred into human
cells in dependency of a functional VirB/VirD4 T4SS and the
plasmid encoded relaxase. This pathogenesis-associated T4SS
has most likely evolved from an ancestral bacterial conjugation
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Fig. 1. B. henselae translocates plasmid DNA into human cells via the VirB/VirD4 T4SS. Ea.hy926 cells were infected with B. henselae WT or ΔvirB4 strains
harboring the indicated plasmids. Plasmid transfer was monitored by measuring GFP ﬂuorescence at 72 h of infection. (A) Schematic representation of the
reporter plasmid pRS117 carrying an eukaryotic gfp-expression cassette (PCMV, egfp) plus plasmid mobilization factors (oriT, mob). Derivatives of this plasmid
include a disruption ofmob (pRGS06) and a fusion of the C-terminal BID domain of BepD to Mob (pRS122). (B) Percentage of gpc of infected cell populations,
monitored by FACS analysis. The values indicated by an asterisk are below the detection limit (<0.003%). (C) Representative FACS proﬁles. FL-1, relative GFP
ﬂuorescence intensity; FSC, forward scatter. (D) Fluorescence microscopic picture (GFP channel) of a cell preparation infected with B. henselae WT carrying
pRS122. The image was overlaid with a phase contrast picture of the same microscopic ﬁeld. (Scale bar: 10 μm.) (E) Model view of the B. henselae VirB/VirD4
T4SS apparatus transporting plasmid DNA into a human host cell. Eleven components, including the ATPases VirB4, VirB11, and VirD4 (indicated as B4, B11,
and D4, respectively), form a channel-spanning inner membrane (IM), periplasm (PP), peptidoglycan (PG), and outer membrane (OM) of the bacterium, plus
the cellular membrane (CM) of the human host cell.
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system into an efﬁcient device for effector protein delivery into
mammalian host cells (2). Considering the evolutionary origin of
this secretion system, the capacity to transfer DNA may not
necessarily serve a particular virulence function like in A.
tumefaciens, but may rather represent a relic of its ancestral role
as conjugation system. This is also suggested by the notion that
the cryptic plasmid pBGR1 encodes proteins with exclusive
functions in plasmid replication and mobilization, i.e., the rep-
lication protein Rep and the relaxase Mob, respectively. More-
over, the lack of an efﬁcient ssDNA protection and nuclear
delivery system in the recipient host cells supports this assump-
tion. Finally, our analysis demonstrated that the Mob relaxase
can protect the 5′ end of the transferred DNA during the
transformation process, as described for the VirD2 protein of
A. tumefaciens (30, 31).
The adaptation of the B. henselae VirB/VirD4 T4SS to human
cells and its versatility for DNA transfer increases its potential
for an application not only for protein therapy as described
previously (19), but also for gene therapy and vaccination. In
contrast to most other established gene delivery systems (32–34),
conjugative DNA transfer may allow the transfer of very large
DNA segments such as bacterial artiﬁcial chromosomes. By
drastically increasing DNA transfer efﬁciency via fusion of the C-
terminal secretion signal of BepD to the Mob relaxase, we have
made a step toward the development of a potential tool for
in vivo gene therapy in humans. Improvements of this system by
assisting the steps following gene delivery, for increasing the
efﬁciency of nuclear targeting and genomic integration, would
need to follow.
Materials and Methods
Bacterial Strains, Cell Lines, and Growth Conditions. B. henselae and Escher-
ichia coli strains were grown as described (21, 35). Bacterial strains used in
this study and their origins are listed in Table S2. The endothelial cell line Ea.
hy926, generated by fusion of human umbilical vein endothelial cells and
the lung carcinoma cell line A549 was cultured as described previously (36).
The cell line Ea.hy926/pRS56-c#B1 was cultured as described previously (19).
Plasmid Constructions. DNA manipulations were carried out according to
standard procedures (37). The plasmids used in this study are listed in Table 1.
Plasmid DNA isolation and PCR puriﬁcation were performed with Qiagen or
Macherey and Nagel columns according to the manufacturer’s instructions.
E. coli NovaBlue was used for cloning steps and the dap− E. coli strain β2150
for plasmid mobilization to B. henselae (38). For construction of pRS117, the
1861 bp HincII-AﬂIII fragment of pWay19 (gift from the Molecular Motion
Laboratory, Montana State University, Bozeman, MT) containing the egfp
gene under the control of the CMV promoter was blunt-ended by using
Klenow polymerase and ligated with HincII cleaved pBGR-K18, a derivative
of pBGR1 (20). The plasmid containing the egfp gene and the kan gene in
the same orientation was selected, yielding pRS117. For construction of
pRS122, a 567-bp fragment encoding the secretion signal of B. henselae
BepD ﬂanked by two AgeI restriction sites, obtained by using pRS51 as
template and the oligonucleotides prRS350 and prRS351 (Table S3), was li-
gated with pRS117, and the plasmid containing the fragment in the correct
orientation resulting in a fusion with the mob gene was selected. For con-
struction of pRGS06, pCHF01 (20) was digested with SalI/XmaI/NcoI and the
2,541-bp SalI-XmaI fragment containing the disruptedmob gene was ligated
with pRS122 (SalI/XmaI). pRS130 was obtained by introducing the 1514 bp
SnaBI-EcoRV fragment of pRS56 (19) containing the neo gene into HincII-
cleaved pRS129. pRS129, in turn, was constructed by ligating a 2,990-bp SalI-
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Fig. 2. Integration of translocated plasmid DNA into the host cell chro-
mosome. Following infection of Ea.hy926 cells with B. henselae strain
RSE581 carrying the reporter plasmid pRS130, eight individual cell lines
(named A–H) where isolated. (A) Schematic representation shows which
parts of plasmid pRS130 have integrated into the genome of recombinant
cell lines A–H, based on Southern blot analysis (Fig. S1 and SI Results) and
PCR analysis (Table S1). A total of 13 different primer pairs (numbered 1–13)
were tested on each cell line for presence (green box) or absence (red open
box) of the targeted sequence. Note that the leftmost amplicon spans the
oriT of pRS130. The border presented in B is indicated by an asterisk and the
borders presented in Fig. S2 are marked by a number sign (#). (B) Nucleotide
sequence alignment of the oriT region of pRS130, the isolated integration
junction of the transferred DNA [line C (5′)], and the human DNA sequence
(accession no. AC108035). The oriT of pRS130 [as deﬁned in the parental
plasmid pBGR1 (20)] is highlighted in black, and the start codon of the mob
gene is marked by three asterisks. Homology of the junction fragment to
pRS130 or AC108035 is indicated by open boxes. In the 47-bp spacer region
that does not show colinearity to either donor or recipient sequence, the 22
nucleotides upstream from the oriT are found as an inverted element (gray
arrow). Homologies to pRS130 or AC108035 within these 47 bp are in-
dicated; 240 bp of the isolated fragment, centered around the integration
site, are displayed.
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PstI fragment of pCX-eGFP (39) containing an egfp expression cassette in-
cluding the chicken β-actin promoter and the CMV-IE enhancer sequence,
with pLRS122. The primer sequences are provided in Table S3.
Detection of DNA or Protein Transfer from B. henselae into Human Endothelial
Cells. Infections of Ea.hy926 (to measure DNA transfer) and Ea.hy926/pRS56-
c#B1 cells (to measure protein transfer) with B. henselae strains were per-
formed as described (19, 21), and the multiplicity of infection (34) and du-
ration of infection were as indicated in the text and ﬁgure legends. The
higher protein transfer rates obtained in the present work versus the rates
obtained previously (19) are related to the use of M199/10% FCS growth
medium instead of DMEM/10% FCS during the infection, resulting in
a higher activation of the VirB/VirD T4SS (40). After infections, cells were
trypsinized, recovered in growth medium, and 4 × 104 to 1 × 105 cells were
analyzed by using a FACSCalibur ﬂow cytometer (Becton Dickinson).
Establishment of Stably Transformed Cell Lines. After initial infection of Ea.
hy926 cells with B. henselae carrying pRS130 (strain RSE581), the cell growth
medium was supplemented with gentamicin (20 mg/L) to kill the bacteria.
Serial dilutions of the cells were then cultured in cell growth medium con-
taining G418 (500 mg/L), and clonal colonies were propagated in this me-
dium for isolation of individual cell lines.
PCR Analysis of the Transgenic Cell Lines. Genomic DNA isolated from the
eight cell lines analyzed by Southern blot hybridization (Fig. S1 and SI
Materials and Methods) was used for PCR detection of 13 different probes
scattered across the entire sequence of pRS130. Genomic DNA from un-
transformed Ea.hy926 cells and the same DNA spiked with puriﬁed pRS130
were used as negative and positive control, respectively. PCR was carried out
in 96-well format in 25 μL volume per reaction containing 2.5 ng genomic
DNA, 30 nM of each primer, and 1× Power SYBR Green PCR Mix (Applied
Biosystems). Ampliﬁcations were carried out according to the manu-
facturer’s instruction by using a StepOnePlus instrument (Applied Bio-
systems) and were analyzed for presence/absence of the targeted sequence
by using StepOne software (Applied Biosystems). Sequences of the primers
used for the PCR analysis are provided in Table S3.
Ampliﬁcation of Integration Site by TAIL-PCR. TAIL-PCR was performed as
described for mapping the genomic integration site of T-DNA insertions in
Arabidopsis (25) or in HeLa cells (10). In brief, a set of three adjacent gene-
speciﬁc primers (GSPs) facing the predicted DNA breakpoint of the in-
tegrated pRS130 were used in combination with two different arbitrary
degenerated (AD) primers in three consecutive PCR reactions on genomic
DNA isolated from the stable Ea.hy926 cell lines. The oligonucleotides
sequences are provided in Table S3. The ﬁrst PCR contained 100 μg of ge-
nomic DNA, 400 μM of dNTPs, 0.2 μM of the ﬁrst GSP, 1 μM of either AD
primer, and 2 U of FastStart Taq DNA polymerase (Roche) in 1× reaction
buffer supplemented with GC-RICH resolution solution. PCR ampliﬁcation
was performed as follows: 6 min at 95 °C, followed by 10 cycles of 30 s at
95 °C, 30 s at 63 °C, and 3 min at 72 °C, followed by one cycle at 95 °C for 30 s,
25°C for 3 min, 72 °C for 2.5 min, and 15 cycles of 30 s at 95 °C, 30 s at 63 °C,
2.5 min at 72 °C, 30 s at 95 °C, 30 s at 63 °C, 2.5 min at 72 °C, 30 s at 95 °C,
1 min at 44 °C, and 2.5 min at 72 °C. One microliter of the resulting reaction
was used as template for the second PCR with the same reaction condition
except the use of the second nested GSP, and incubated for 6 min at 95 °C
followed by 15 cycles of 30 s at 95 °C, 30 s at 63 °C, 2.5 min at 72 °C, 30 s at
95 °C, 30 s at 63 °C, 2.5 min at 72 °C, 30 s at 95 °C, 30 s at 44 °C, and 2.5 min at
72 °C. Finally, 1 μL of the secondary reaction was used as template to set up
the tertiary ampliﬁcation by using a third nested GSP and incubated for 6
min at 95 °C followed by 12 cycles of 30 s at 95 °C, 30 s at 44 °C, and 2.5 min
at 72 °C. The resulting ampliﬁed PCR product was cloned into a pGEM-T Easy
plasmid (Promega) and analyzed by sequencing. The obtained integration
site was veriﬁed by independent PCR ampliﬁcation by using a primer
annealing to the human genome (designed based on the obtained TAIL-PCR
sequence information) and a second primer annealing on pRS130, followed
by cloning and sequence analysis.
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